Cytek® Biosciences (CTKB) Announces $50M Share Buyback

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. DRS
4. GS
5. BAC
6. ORCL
7. AVAV
8. ACI
9. UNH
10. SPY

Go back to Cytek® Biosciences (CTKB) Announces $50M Share Buyback

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

December 30, 2024 8:00 AM EST

FREMONT, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved a stock repurchase program for up to an additional aggregate of $50 million of its common stock, subject to compliance with applicable law, to succeed the expiration of the existing $50 million repurchase program on December 31, 2024. The new repurchase program is authorized to commence on January 1, 2025 and remain in effect until December 31, 2025 unless extended or shortened by the Board of Directors.

Any... More